文献速递冠心病心力衰竭与心肌病心律失常

北美心脏重症监护病房患者人口学、诊疗模式与结局:CCCTN前瞻性多中心注册研究

Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness.
PubMed 文献 · JAMA Cardiol · 2019-01-01

该研究建立CCCTN网络,纳入16个美加三级医院CICU连续收治的3049例患者,分析人口学、诊断、治疗与结局。主要入住指征为呼吸功能不全和休克,CICU总死亡率为8.3%,心脏骤停、心源性休克和肾脏替代治疗者死亡率最高,而仅术后观察或监测者死亡率极低。

要点

  • CICU入住的首要诊断是急性冠脉综合征(31.8%)和心力衰竭(18.6%),但各中心ACS比例差异大(15%-57%)。
  • 呼吸功能不全(26.7%)和休克(21.1%)是CICU主要收治指征,且预后较差。
  • CICU总死亡率为8.3%,心脏骤停、心源性休克和需肾脏替代治疗者死亡率最高。

核心结论

  • 在当代三级医院CICU网络中,呼吸衰竭和休克是主要入住指征且预后不良,同时存在大量低风险人群。

研究设计与样本

  • 研究建立CCCTN,为美国与加拿大16个高级三级CICU的多中心前瞻性注册研究。
  • 每个CICU连续收集2个月收治数据,最终纳入3049例医疗CICU首次入院患者进行分析。

主要发现

  • 3049例患者中女性1132例(37.1%),有色人种797例(31.4%),中位年龄65岁(25-75百分位55-75岁)。
  • 主要CICU入住诊断:急性冠脉综合征969例(31.8%)、心力衰竭567例(18.6%),但ACS占比各中心间变异大(15%-57%)。
  • CICU收治指征:呼吸功能不全814例(26.7%)、休克643例(21.1%)、不稳定心律失常521例(17.1%)、心脏骤停265例(8.7%)。
  • 1776例(58.2%)需要高级CICU治疗或监测,包括静脉血管活性药物1105例(36.2%)、有创血流动力学监测938例(30.8%)、机械通气652例(21.4%)。
  • 总CICU死亡率为8.3%(95%CI 7.3%-9.3%);死亡率最高的指征为心脏骤停101例(38.1%)、心源性休克140例(30.6%)、需肾脏替代治疗51例(34.5%)。

关键数值与推荐

  • 仅因术后观察或频繁监测入住的患者死亡率为0.2%至0.4%。

临床怎么用

  • 临床需关注CICU中呼吸衰竭和休克患者的高死亡风险,并识别仅需监测的低风险人群以优化资源配置。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Single-center and claims-based studies have described substantial changes in the landscape of care in the cardiac intensive care unit (CICU). Professional societies have recommended research to guide evidence-based CICU redesigns. OBJECTIVE: To characterize patients admitted to contemporary, advanced CICUs. DESIGN, SETTING, AND PARTICIPANTS: This study established the Critical Care Cardiology Trials Network (CCCTN), an investigator-initiated multicenter network of 16 advanced, tertiary CICUs in the United States and Canada. For 2 months in each CICU, data for consecutive admissions were submitted to the central data coordinating center (TIMI Study Group). The data were collected and analyzed between September 2017 and 2018. MAIN OUTCOMES AND MEASURES: Demographics, diagnoses, management, and outcomes. RESULTS: Of 3049 participants, 1132 (37.1%) were women, 797 (31.4%) were individuals of color, and the median age was 65 years (25th and 75th percentiles, 55-75 years). Between September 2017 and September 2018, 3310 admissions were included, among which 2557 (77.3%) were for primary cardiac problems, 337 (10.2%) for postprocedural care, 253 (7.7%) for mixed general and cardiac problems, and 163 (4.9%) for overflow from general medical ICUs. When restricted to the initial 2 months of medical CICU admissions for each site, the primary analysis population included 3049 admissions with a high burden of noncardiovascular comorbidities. The top 2 CICU admission diagnoses were acute coronary syndrome (969 [31.8%]) and heart failure (567 [18.6%]); however, the proportion of acute coronary syndrome was highly variable across centers (15%-57%). The primary indications for CICU care included respiratory insufficiency (814 [26.7%]), shock (643 [21.1%]), unstable arrhythmia (521 [17.1%]), and cardiac arrest (265 [8.7%]). Advanced CICU therapies or monitoring were required for 1776 patients (58.2%), including intravenous vasoactive medications (1105 [36.2%]), invasive hemodynamic monitoring (938 [30.8%]), and mechanical ventilation (652 [21.4%]). The overall CICU mortality rate was 8.3% (95% CI, 7.3%-9.3%). The CICU indications that were associated with the highest mortality rates were cardiac arrest (101 [38.1%]), cardiogenic shock (140 [30.6%]), and the need for renal replacement therapy (51 [34.5%]). Notably, patients admitted solely for postprocedural observation or frequent monitoring had a mortality rate of 0.2% to 0.4%. CONCLUSIONS AND RELEVANCE: In a contemporary network of tertiary care CICUs, respiratory failure and shock predominated indications for admission and carried a poor prognosis. While patterns of practice varied considerably between centers, a substantial, low-risk population was identified. Multicenter collaborative networks, such as the CCCTN, could be used to help redesign cardiac critical care and to test new therapeutic strategies.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Bohula EA, Katz JN, van Diepen S, et al. Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness. JAMA Cardiol. 2019. PMID: 31339509. doi:10.1001/jamacardio.2019.2467

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。